Format

Send to

Choose Destination
Eur Heart J. 2018 Aug 7;39(30):2793-2799. doi: 10.1093/eurheartj/ehx027.

Transitioning from usual care to biomarker-based personalized and precision medicine in heart failure: call for action.

Author information

1
Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
2
Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
3
CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.
4
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
5
INSERM, CIC1433, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
6
Cardiology Division, Massachusetts General Hospital, Boston, MA, USA.
7
Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
8
Cardiovascular Research Institute, National University of Singapore, Singapore.
9
Program of Cardiovascular Diseases, Center for Applied Medical Research, University of Navarra, Pamplona, Spain.
10
Department of Cardiology and Cardiac Surgery, University Clinic, University of Navarra, Pamplona, Spain.
PMID:
28204449
DOI:
10.1093/eurheartj/ehx027

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center